These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Stereotactic Body Radiation Therapy for Oligometastatic Ovarian Cancer: A Step Toward a Drug Holiday. Lazzari R; Ronchi S; Gandini S; Surgo A; Volpe S; Piperno G; Comi S; Pansini F; Fodor C; Orecchia R; Tomao F; Parma G; Colombo N; Jereczek-Fossa BA Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):650-660. PubMed ID: 29893277 [TBL] [Abstract][Full Text] [Related]
4. Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph Nodes. Jereczek-Fossa BA; Fanetti G; Fodor C; Ciardo D; Santoro L; Francia CM; Muto M; Surgo A; Zerini D; Marvaso G; Timon G; Romanelli P; Rondi E; Comi S; Cattani F; Golino F; Mazza S; Matei DV; Ferro M; Musi G; Nolè F; de Cobelli O; Ost P; Orecchia R Clin Genitourin Cancer; 2017 Aug; 15(4):e623-e632. PubMed ID: 28185875 [TBL] [Abstract][Full Text] [Related]
5. Stereotactic Body Radiotherapy for Recurrent or Oligometastatic Uterine Cervix Cancer: A Cooperative Study of the Korean Radiation Oncology Group (KROG 14-11). Park HJ; Chang AR; Seo Y; Cho CK; Jang WI; Kim MS; Choi C Anticancer Res; 2015 Sep; 35(9):5103-10. PubMed ID: 26254414 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors. Barney BM; Olivier KR; Macdonald OK; Fong de Los Santos LE; Miller RC; Haddock MG Am J Clin Oncol; 2012 Dec; 35(6):537-42. PubMed ID: 21659830 [TBL] [Abstract][Full Text] [Related]
7. Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastases. Bignardi M; Navarria P; Mancosu P; Cozzi L; Fogliata A; Tozzi A; Castiglioni S; Carnaghi C; Tronconi MC; Santoro A; Scorsetti M Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):831-8. PubMed ID: 20800375 [TBL] [Abstract][Full Text] [Related]
8. Is Stereotactic Body Radiotherapy (SBRT) in lymph node oligometastatic patients feasible and effective? Jereczek-Fossa BA; Ronchi S; Orecchia R Rep Pract Oncol Radiother; 2015; 20(6):472-83. PubMed ID: 26696788 [TBL] [Abstract][Full Text] [Related]
9. Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis. Ost P; Jereczek-Fossa BA; As NV; Zilli T; Muacevic A; Olivier K; Henderson D; Casamassima F; Orecchia R; Surgo A; Brown L; Tree A; Miralbell R; De Meerleer G Eur Urol; 2016 Jan; 69(1):9-12. PubMed ID: 26189689 [TBL] [Abstract][Full Text] [Related]
10. Salvage Stereotactic Body Radiotherapy for Patients With Prostate Cancer With Isolated Lymph Node Metastasis: A Single-Center Experience. Ponti E; Ingrosso G; Carosi A; Di Murro L; Lancia A; Pietrasanta F; Santoni R Clin Genitourin Cancer; 2015 Aug; 13(4):e279-e284. PubMed ID: 25604915 [TBL] [Abstract][Full Text] [Related]
11. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how? Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659 [TBL] [Abstract][Full Text] [Related]
12. Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases. Yeung R; Hamm J; Liu M; Schellenberg D Radiat Oncol; 2017 Jun; 12(1):105. PubMed ID: 28637480 [TBL] [Abstract][Full Text] [Related]
13. Radiotherapy for the treatment of distant nodes metastases from oligometastatic urothelial cancer: A retrospective case series. Leonetti A; D'Abbiero N; Baldari G; Andreani S; Ruffini L; Viansone AA; Buti S Int J Urol; 2018 Oct; 25(10):879-886. PubMed ID: 30103254 [TBL] [Abstract][Full Text] [Related]
14. A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups. Macchia G; Lazzari R; Colombo N; Laliscia C; Capelli G; D'Agostino GR; Deodato F; Maranzano E; Ippolito E; Ronchi S; Paiar F; Scorsetti M; Cilla S; Ingargiola R; Huscher A; Cerrotta AM; Fodor A; Vicenzi L; Russo D; Borghesi S; Perrucci E; Pignata S; Aristei C; Morganti AG; Scambia G; Valentini V; Jereczek-Fossa BA; Ferrandina G Oncologist; 2020 Feb; 25(2):e311-e320. PubMed ID: 32043791 [TBL] [Abstract][Full Text] [Related]
15. Role of Stereotactic Body Radiation Therapy with Volumetric-Modulated Arcs and High-Intensity Photon Beams for the Treatment of Abdomino-Pelvic Lymph-Node Metastases. Franzese C; Cozzi L; Franceschini D; D'Agostino G; Comito T; De Rose F; Navarria P; Mancosu P; Tomatis S; Fogliata A; Scorsetti M Cancer Invest; 2016 Aug; 34(7):348-54. PubMed ID: 27414125 [TBL] [Abstract][Full Text] [Related]
16. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach. Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057 [TBL] [Abstract][Full Text] [Related]
17. Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy. Ponti E; Lancia A; Ost P; Trippa F; Triggiani L; Detti B; Ingrosso G Eur Urol Focus; 2017 Dec; 3(6):538-544. PubMed ID: 28801240 [TBL] [Abstract][Full Text] [Related]
18. Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences. Ost P; Jereczek-Fossa BA; Van As N; Zilli T; Tree A; Henderson D; Orecchia R; Casamassima F; Surgo A; Miralbell R; De Meerleer G Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e115-20. PubMed ID: 27133946 [TBL] [Abstract][Full Text] [Related]
19. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
20. Recurrent oligometastatic transitional cell bladder carcinoma: is there room for radiotherapy? Augugliaro M; Marvaso G; Ciardo D; Zerini D; Riva G; Rondi E; Vigorito S; Comi S; De Cobelli O; Orecchia R; Jereczek-Fossa BA Neoplasma; 2019 Jan; 66(1):160-165. PubMed ID: 30509099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]